Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
Clearmind Medicine Inc. Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0)…
Read MoreExperience In Health
Clearmind Medicine Inc. Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0)…
Read MoreCredit: MART PRODUCTION from Pexels A new study shows that a non-invasive imaging test can help identify patients…
Read MoreProthea is developing an imaging medical device that combines microendoscope with an image processing system to enhance lesion…
Read MoreThe Food and Drug Administration (FDA) approved the gene therapy Casgevy in December, which uses CRISPR/Cas9 genome editing…
Read MoreThe PCB’s medical management of fast bowlers is again under the microscope after it emerged that Pakistan and…
Read MoreLatest Mental Health News By Dennis Thompson HealthDay Reporter MONDAY, April 1, 2024 A monthly long-acting…
Read More